|
2026-03-05 |
2026-03-04 |
S
Sale
|
PRESIDENT and CEO
Executive Director
|
94,883
+18.0%
458.68
US$1,554,291
|
94,883
+18.0%
|
458.68
|
US$1,554,291
|
|
|
2026-03-05 |
2026-03-04 |
S
Sale
|
CHIEF FINANCIAL OFFICER
Officer
|
93,329
-16.4%
408.72
US$658,119
|
93,329
-16.4%
|
408.72
|
US$658,119
|
|
|
2026-03-05 |
2026-03-04 |
S
Sale
|
GENERAL COUNSEL and CCO
Officer
|
84,600
-17.1%
147.12
US$1,327,675
|
84,600
-17.1%
|
147.12
|
US$1,327,675
|
|
|
2026-03-05 |
2026-03-04 |
S
Sale
|
CHIEF SCIENTIFIC OFFICER
Officer
|
1,359
-5.1%
5.37
US$7,298
|
1,359
-5.1%
|
5.37
|
US$7,298
|
|
|
2026-03-05 |
2026-03-04 |
S
Sale
|
CHIEF MEDICAL OFFICER
Officer
|
1,720
-9.8%
5.37
US$9,236
|
1,720
-9.8%
|
5.37
|
US$9,236
|
|
|
2026-03-04 |
2026-03-04 |
PrS
Proposed sale
|
Officer; Director
Executive Director
|
5,156
5.36
US$27,662
|
5,156
|
5.36
|
US$27,662
|
|
|
2026-01-05 |
2026-01-02 |
S
Sale
|
President and CEO
Executive Director
|
2,586
-6.0%
6.88
US$17,792
|
2,586
-6.0%
|
6.88
|
US$17,792
|
|
|
2026-01-05 |
2026-01-02 |
S
Sale
|
Chief Financial Officer
Officer
|
297
-2.3%
6.88
US$2,043
|
297
-2.3%
|
6.88
|
US$2,043
|
|
|
2026-01-05 |
2026-01-02 |
S
Sale
|
CHIEF MEDICAL OFFICER
Officer
|
1,644
-13.9%
6.88
US$11,311
|
1,644
-13.9%
|
6.88
|
US$11,311
|
|
|
2026-01-05 |
2026-01-02 |
S
Sale
|
CHIEF SCIENTIFIC OFFICER
Officer
|
876
-4.1%
6.88
US$6,027
|
876
-4.1%
|
6.88
|
US$6,027
|
|
|
2026-01-05 |
2026-01-02 |
S
Sale
|
General Counsel and CCO
Officer
|
876
-5.9%
6.88
US$6,027
|
876
-5.9%
|
6.88
|
US$6,027
|
|
|
2025-07-02 |
2025-07-01 |
S
Sale
|
SVP, Finance and Accounting
Officer
|
2,897
-2.6%
0.29
US$850
|
2,897
-2.6%
|
0.29
|
US$850
|
|
|
2025-07-02 |
2025-07-01 |
S
Sale
|
General Counsel and CCO
Officer
|
8,526
-7.1%
0.29
US$2,502
|
8,526
-7.1%
|
0.29
|
US$2,502
|
|
|
2025-07-02 |
2025-07-01 |
S
Sale
|
CHIEF SCIENTIFIC OFFICER
Officer
|
8,526
-4.8%
0.29
US$2,502
|
8,526
-4.8%
|
0.29
|
US$2,502
|
|
|
2025-07-02 |
2025-07-01 |
S
Sale
|
President and CEO
Executive Director
|
25,123
-7.2%
0.29
US$7,374
|
25,123
-7.2%
|
0.29
|
US$7,374
|
|
|
2025-07-02 |
2025-07-01 |
S
Sale
|
CHIEF MEDICAL OFFICER
Officer
|
10,842
-13.1%
0.29
US$3,182
|
10,842
-13.1%
|
0.29
|
US$3,182
|
|
|
2025-07-01 |
2025-07-01 |
PrS
Proposed sale
|
Officer; Director
Executive Director
|
25,123
0.29
US$7,374
|
25,123
|
0.29
|
US$7,374
|
|
|
2025-07-01 |
2025-07-01 |
PrS
Proposed sale
|
Officer
Officer
|
10,842
0.29
US$3,182
|
10,842
|
0.29
|
US$3,182
|
|
|
2025-07-01 |
2025-07-01 |
PrS
Proposed sale
|
Officer
Officer
|
8,526
0.29
US$2,502
|
8,526
|
0.29
|
US$2,502
|
|
|
2025-07-01 |
2025-07-01 |
PrS
Proposed sale
|
Officer
Officer
|
8,526
0.29
US$2,502
|
8,526
|
0.29
|
US$2,502
|
|
|
2025-01-03 |
2025-01-02 |
S
Sale
|
CHIEF MEDICAL OFFICER
Officer
|
10,826
-23.2%
0.56
US$6,083
|
10,826
-23.2%
|
0.56
|
US$6,083
|
|
|
2025-01-03 |
2025-01-02 |
S
Sale
|
General Counsel and CCO
Officer
|
8,510
-9.2%
0.56
US$4,782
|
8,510
-9.2%
|
0.56
|
US$4,782
|
|
|
2025-01-03 |
2025-01-02 |
S
Sale
|
VP of Finance
Officer
|
2,881
-3.1%
0.56
US$1,619
|
2,881
-3.1%
|
0.56
|
US$1,619
|
|
|
2025-01-03 |
2025-01-02 |
S
Sale
|
President and CEO
Executive Director
|
25,107
-9.4%
0.56
US$14,108
|
25,107
-9.4%
|
0.56
|
US$14,108
|
|
|
2025-01-03 |
2025-01-02 |
S
Sale
|
CHIEF SCIENTIFIC OFFICER
Officer
|
8,510
-6.1%
0.56
US$4,782
|
8,510
-6.1%
|
0.56
|
US$4,782
|
|
|
2025-01-02 |
2025-01-02 |
PrS
Proposed sale
|
Officer
Officer
|
10,826
0.56
US$6,083
|
10,826
|
0.56
|
US$6,083
|
|
|
2025-01-02 |
2025-01-02 |
PrS
Proposed sale
|
Officer; Director
Executive Director
|
25,107
0.56
US$14,108
|
25,107
|
0.56
|
US$14,108
|
|
|
2025-01-02 |
2025-01-02 |
PrS
Proposed sale
|
Officer
Officer
|
8,510
0.56
US$4,782
|
8,510
|
0.56
|
US$4,782
|
|
|
2025-01-02 |
2025-01-02 |
PrS
Proposed sale
|
Officer
Officer
|
8,510
0.56
US$4,782
|
8,510
|
0.56
|
US$4,782
|
|
|
2024-09-05 |
2024-09-05 |
PrS
Proposed sale
|
Officer; Director
Executive Director
|
5,032
0.00
US$1
|
5,032
|
0.00
|
US$1
|
|
|
2024-09-05 |
2024-09-05 |
S
Sale
|
COO and CDO
Officer
|
2,525
-10.8%
0.57
US$1,429
|
2,525
-10.8%
|
0.57
|
US$1,429
|
|
|
2024-09-05 |
2024-09-05 |
S
Sale
|
GENERAL COUNSEL
Officer
|
2,525
-4.6%
0.57
US$1,429
|
2,525
-4.6%
|
0.57
|
US$1,429
|
|
|
2024-09-05 |
2024-09-05 |
S
Sale
|
CHIEF SCIENTIFIC OFFICER
Officer
|
2,525
-2.7%
0.57
US$1,429
|
2,525
-2.7%
|
0.57
|
US$1,429
|
|
|
2024-09-05 |
2024-09-05 |
S
Sale
|
CFO and Chief Business Officer
Officer
|
1,272
-1.3%
0.57
US$720
|
1,272
-1.3%
|
0.57
|
US$720
|
|
|
2024-09-05 |
2024-09-05 |
S
Sale
|
President and CEO
Executive Director
|
5,032
-3.1%
0.57
US$2,848
|
5,032
-3.1%
|
0.57
|
US$2,848
|
|
|
2024-06-25 |
2024-06-24 |
B
Purchase
|
Non-Executive Director
|
27,400
+51.4%
2.42
US$66,179
|
27,400
+51.4%
|
2.42
|
US$66,179
|
|
|
2024-06-25 |
2024-06-21 |
B
Purchase
|
Non-Executive Director
|
15,000
+39.1%
2.26
US$33,872
|
15,000
+39.1%
|
2.26
|
US$33,872
|
|
|
2024-01-08 |
2024-01-05 |
S
Sale
|
Chief Operating Officer
Officer
|
2,412
-15.3%
2.91
US$7,019
|
2,412
-15.3%
|
2.91
|
US$7,019
|
|
|
2024-01-08 |
2024-01-05 |
S
Sale
|
General Counsel
Officer
|
2,412
-6.5%
2.91
US$7,019
|
2,412
-6.5%
|
2.91
|
US$7,019
|
|
|
2024-01-08 |
2024-01-05 |
S
Sale
|
Chief Executive Officer
Executive Director
|
4,820
-3.2%
2.91
US$14,026
|
4,820
-3.2%
|
2.91
|
US$14,026
|
|
|
2023-12-29 |
2023-12-29 |
B
Purchase
|
Non-Executive Director
Large shareholder
|
163,954
+3.1%
2.38
US$390,211
|
163,954
+3.1%
|
2.38
|
US$390,211
|
|
|
2023-12-29 |
2023-12-28 |
B
Purchase
|
Non-Executive Director
Large shareholder
|
409,598
+8.5%
2.44
US$999,419
|
409,598
+8.5%
|
2.44
|
US$999,419
|
|
|
2023-12-29 |
2023-12-27 |
B
Purchase
|
Non-Executive Director
Large shareholder
|
32,134
+0.7%
2.28
US$73,266
|
32,134
+0.7%
|
2.28
|
US$73,266
|
|
|
2023-06-09 |
2023-06-07 |
B
Purchase
|
See Below
Officer
|
11,719
+17.2%
3.44
US$40,308
|
11,719
+17.2%
|
3.44
|
US$40,308
|
|
|
2023-06-09 |
2023-06-07 |
B
Purchase
|
See Below
Officer
|
2,859
+4.4%
3.40
US$9,721
|
2,859
+4.4%
|
3.40
|
US$9,721
|
|
|
2023-06-09 |
2023-06-07 |
B
Purchase
|
See Below
Officer
|
422
+0.6%
3.36
US$1,417
|
422
+0.6%
|
3.36
|
US$1,417
|
|
|
2023-06-06 |
2023-06-05 |
B
Purchase
|
See Below
Officer
|
10,000
+18.2%
3.02
US$30,154
|
10,000
+18.2%
|
3.02
|
US$30,154
|
|
|
2023-06-06 |
2023-06-05 |
B
Purchase
|
See Below
Officer
|
10,000
+22.2%
3.00
US$29,999
|
10,000
+22.2%
|
3.00
|
US$29,999
|
|
|
2023-06-06 |
2023-06-05 |
B
Purchase
|
See Below
Officer
|
10,000
+28.6%
3.00
US$29,997
|
10,000
+28.6%
|
3.00
|
US$29,997
|
|
|
2023-06-06 |
2023-06-05 |
B
Purchase
|
See Below
Officer
|
15,000
+75.0%
3.00
US$45,000
|
15,000
+75.0%
|
3.00
|
US$45,000
|
|
|
2023-06-06 |
2023-06-02 |
B
Purchase
|
See Below
Officer
|
3,418
+20.6%
2.95
US$10,066
|
3,418
+20.6%
|
2.95
|
US$10,066
|
|
|
2023-06-06 |
2023-06-02 |
B
Purchase
|
See Below
Officer
|
6,582
+65.7%
2.86
US$18,823
|
6,582
+65.7%
|
2.86
|
US$18,823
|
|
|
2023-06-06 |
2023-06-02 |
B
Purchase
|
See Below
Officer
|
10,012
+inf%
2.75
US$27,533
|
10,012
+inf%
|
2.75
|
US$27,533
|
|
|
2023-03-30 |
2023-03-29 |
B
Purchase
|
Non-Executive Director
|
5,000
+inf%
2.40
US$12,000
|
5,000
+inf%
|
2.40
|
US$12,000
|
|
|
2024-01-08 |
2023-01-05 |
S
Sale
|
See Below
Officer
|
1,208
-1.4%
2.91
US$3,515
|
1,208
-1.4%
|
2.91
|
US$3,515
|
|
|
2024-01-08 |
2023-01-05 |
S
Sale
|
Chief Scientific Officer
Officer
|
2,412
-2.9%
2.91
US$7,019
|
2,412
-2.9%
|
2.91
|
US$7,019
|
|
|
2022-12-30 |
2022-12-28 |
B
Purchase
|
Chief Financial Officer
Officer
|
50,000
+45.5%
2.85
US$142,250
|
50,000
+45.5%
|
2.85
|
US$142,250
|
|
|
2022-12-06 |
2022-12-02 |
B
Purchase
|
Non-Executive Director
|
30,000
+360.8%
3.29
US$98,700
|
30,000
+360.8%
|
3.29
|
US$98,700
|
|
|
2022-11-17 |
2022-11-15 |
B
Purchase
|
Chief Medical Officer
Officer
|
5,000
+8.2%
3.29
US$16,442
|
5,000
+8.2%
|
3.29
|
US$16,442
|
|
|
2022-07-01 |
2022-06-30 |
B
Purchase
|
Non-Executive Director
Large shareholder
|
1,101,362
+29.8%
2.99
US$3,293,072
|
1,101,362
+29.8%
|
2.99
|
US$3,293,072
|
|
|
2022-07-01 |
2022-06-29 |
B
Purchase
|
Non-Executive Director
Large shareholder
|
270,000
+7.9%
2.99
US$807,300
|
270,000
+7.9%
|
2.99
|
US$807,300
|
|
|
2022-06-24 |
2022-06-23 |
S
Sale
|
General Counsel
Officer
|
2,614
-12.0%
2.69
US$7,032
|
2,614
-12.0%
|
2.69
|
US$7,032
|
|
|
2022-06-24 |
2022-06-23 |
S
Sale
|
Chief Operating Officer
Officer
|
4,193
-41.9%
2.69
US$11,279
|
4,193
-41.9%
|
2.69
|
US$11,279
|
|
|
2022-06-24 |
2022-06-23 |
S
Sale
|
Chief Executive Officer
Executive Director
|
7,960
-5.8%
2.69
US$21,412
|
7,960
-5.8%
|
2.69
|
US$21,412
|
|
|
2022-06-24 |
2022-06-23 |
S
Sale
|
Chief Financial Officer
Officer
|
2,614
-2.3%
2.69
US$7,032
|
2,614
-2.3%
|
2.69
|
US$7,032
|
|
|
2022-06-24 |
2022-06-23 |
S
Sale
|
Executive VP, Research
Officer
|
2,614
-4.3%
2.69
US$7,032
|
2,614
-4.3%
|
2.69
|
US$7,032
|
|
|
2022-04-01 |
2022-03-31 |
B
Purchase
|
Non-Executive Director
|
8,000
+2539.7%
13.11
US$104,880
|
8,000
+2539.7%
|
13.11
|
US$104,880
|
|
|
2021-01-27 |
2021-01-25 |
B
Purchase
|
Non-Executive Director
Large shareholder
|
311,111
+10.0%
22.50
US$6,999,998
|
311,111
+10.0%
|
22.50
|
US$6,999,998
|
|
|
2020-09-22 |
2020-09-22 |
B
Purchase
|
Non-Executive Director
Large shareholder
|
1,058,824
+51.5%
17.00
US$18,000,008
|
1,058,824
+51.5%
|
17.00
|
US$18,000,008
|
|
|
2020-09-22 |
2020-09-22 |
B
Purchase
|
Large shareholder
|
1,058,824
+51.5%
17.00
US$18,000,008
|
1,058,824
+51.5%
|
17.00
|
US$18,000,008
|
|
|
2020-09-22 |
2020-09-18 |
B
Purchase
|
Large shareholder
|
750,000
+39.1%
17.00
US$12,750,000
|
750,000
+39.1%
|
17.00
|
US$12,750,000
|
|
